Brian Van Tine, MD, discusses the design of the SPEARHEAD-1 trial

Brian Van Tine, ASCO20: Summary of the Phase 1 SPEARHEAD-1 Trial in SarcomaПодробнее

Dr. Van Tine on Next Steps With ADP-A2M4 in Advanced Solid TumorsПодробнее

Spearhead 1 StudyПодробнее

Brian Van Tine, MD, PhDПодробнее

Brian Van Tine, MD, on the most promising investigational agents in advanced sarcomaПодробнее

Updates in Sarcoma: 2023 West OncologyПодробнее

Dr. Van Tine on Collaboration and Clinical Trials in Uterine SarcomaПодробнее

Brian Van Tine, MD, considers the role of real-world outcomes in the treatment of sarcomaПодробнее

SPEARHEAD-1: afamitresgene autoleucel in advanced synovial sarcomaПодробнее

OsteoBites S2 Ep6: Brian Van Tine, MD, PhD on “Osteosarcoma Tumor Metabolism”Подробнее

Integrating the Community Oncologist into the Multidisciplinary TeamПодробнее

SARC Talk Episode 1 - Dr. William Tap & Dr. Brian VanTineПодробнее

Dr. Van Tine on Sequencing Therapies in GISTПодробнее

Toronto Cardiac Tumor Conference 2020 Brian Van TineПодробнее

Understanding Molecular Subtypes of SarcomaПодробнее

Brian Van Tine, ESMO 2019 - Pazopanib in soft tissue sarcomasПодробнее

Hot topics in sarcoma at ASCO 2021Подробнее

Predicative biomarkers of response to immunotherapy in STSПодробнее

ASCO 2013 - Brian Van Tine M.D., PH.D., Molecular ProfilingПодробнее